NEW YORK, March 25, 2016 -- Rosen Law Firm, a global investor rights law firm, reminds investors of Third Avenue Focused Credit Institutional Fund (NASDAQ:TFCIX) and Third Avenue Focused Credit Investor Fund (NASDAQ:TFCVX) (collectively, “Third Avenue”) from March 1, 2013 through December 10, 2015, all dates inclusive (the “Class Period”) of the important March 29, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Third Avenue investors under the federal securities laws.
To join the Third Avenue class action, go to the firm’s website at http://rosenlegal.com/cases-803.html or call Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
The Complaint alleges that Defendants failed to disclose that Third Avenue consistently held more than 15% of its net assets in illiquid securities even though Third Avenue’s Registration Statements and Prospectuses stated that Third Avenue maintained only a small proportion of its investments in illiquid securities and at no point held more than the 15% threshold set by the SEC. When declining asset prices and customer redemptions caused Third Avenue to suspend customer redemptions and place the fund’s assets in a liquidating trust, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 29, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-803.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



